Breaking News, Collaborations & Alliances

Centogene, Molecular Health Partner to Transform Biomedical Research

Aims to foster novel precision medicine environment to accelerate, de-risk, and improve the development of new orphan drugs combining big data and AI.

By: Contract Pharma

Contract Pharma Staff

Centogene N.V., a commercial-stage company focused on rare diseases and Molecular Health, a company in the field of data and computing science for precision medicine, will collaborate exclusively to initiate the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project – starting with Epilepsy as the first indication. RIBA aims to foster a unique novel precision medicine environment to accelerate, de-risk, and improve the development of new orphan drugs based on the combination of la...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters